JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
-0.16%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$54.4M
AUM Growth
+$54.4M
(-13%)
Cap. Flow
-$9.1M
Cap. Flow
% of AUM
-16.74%
Top 10 Holdings %
Top 10 Hldgs %
68.17%
Holding
40
New
6
Increased
5
Reduced
23
Closed
1
Top Buys
| 1 |
Carter's
CRI
|
$12.8M |
| 2 |
UnitedHealth
UNH
|
$1.5M |
| 3 |
HCA Healthcare
HCA
|
$943K |
| 4 |
Incyte
INCY
|
$427K |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$372K |
Top Sells
| 1 |
Nike
NKE
|
$11.4M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$6.2M |
| 3 |
AET
Aetna Inc
AET
|
$1.92M |
| 4 |
VF Corp
VFC
|
$1.12M |
| 5 |
Biogen
BIIB
|
$745K |
Sector Composition
| 1 | Consumer Discretionary | 44.76% |
| 2 | Healthcare | 38.28% |
| 3 | Consumer Staples | 9.89% |
| 4 | Communication Services | 3.97% |
| 5 | Financials | 2.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Carter's
CRI
$1.04B
| $13.6M | 1.32% |
156,605
+147,408
| +1,603% | +$12.8M |
|
|
2
VF Corp
VFC
$5.91B
| $7.51M | 0.73% |
134,000
-20,022
| -13% | -$1.12M |
|
3
Kraft Heinz
KHC
$33.1B
| $2.51M | 0.24% |
27,997
| – | – |
|
4
AB InBev
BUD
$122B
| $2.41M | 0.23% |
18,312
-1,118
| -6% | -$147K |
|
|
5
Alphabet (Google) Class C
GOOG
$2.58T
| $2.16M | 0.21% |
2,777
-7,971
| -74% | -$6.2M |
|
6
Gilead Sciences
GILD
$140B
| $2.05M | 0.2% |
25,908
-933
| -3% | -$73.8K |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $1.91M | 0.19% |
18,261
-5,881
| -24% | -$615K |
|
8
CVS Health
CVS
$92.8B
| $1.85M | 0.18% |
20,817
-2,111
| -9% | -$188K |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.59M | 0.15% |
12,979
-1,291
| -9% | -$158K |
|
10
Thermo Fisher Scientific
TMO
$186B
| $1.52M | 0.15% |
9,553
+1,676
| +21% | +$267K |
|
|
11
UnitedHealth
UNH
$281B
| $1.5M | 0.14% |
+10,677
| New | +$1.5M |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $1.21M | 0.12% |
5,273
-44
| -0.8% | -$10.1K |
|
13
Eli Lilly
LLY
$657B
| $1.14M | 0.11% |
14,154
-2,865
| -17% | -$230K |
|
|
14
Biogen
BIIB
$19.4B
| $1.1M | 0.11% |
3,520
-2,379
| -40% | -$745K |
|
15
AbbVie
ABBV
$372B
| $1M | 0.1% |
15,875
-2,853
| -15% | -$180K |
|
16
BioMarin Pharmaceuticals
BMRN
$11.2B
| $967K | 0.09% |
10,448
+131
| +1% | +$12.1K |
|
|
17
HCA Healthcare
HCA
$94.5B
| $943K | 0.09% |
+12,468
| New | +$943K |
|
18
Regeneron Pharmaceuticals
REGN
$61.5B
| $922K | 0.09% |
2,294
+622
| +37% | +$250K |
|
19
Booking.com
BKNG
$181B
| $714K | 0.07% |
485
-445
| -48% | -$655K |
|
20
Amgen
AMGN
$155B
| $640K | 0.06% |
3,834
-2,515
| -40% | -$420K |
|
21
Moody's
MCO
$91.4B
| $606K | 0.06% |
5,592
-3,303
| -37% | -$358K |
|
22
Visa
V
$683B
| $587K | 0.06% |
7,092
-3,184
| -31% | -$264K |
|
|
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
| $537K | 0.05% |
6,664
+83
| +1% | +$6.69K |
|
24
Home Depot
HD
$405B
| $527K | 0.05% |
4,092
-2,153
| -34% | -$277K |
|
25
Apple
AAPL
$3.45T
| $492K | 0.05% |
4,355
-2,480
| -36% | -$280K |
|